How to use this page
The mental-health side of psoriasis has its own research: depression, anxiety, and the practical question of when and how to ask for support. For work, relationships, school, and family situations, the life and mind hub covers those directly.
If you want the sleep-loss side of a flare, the itch and sleep guide covers that. If you want to know what commonly sets a flare off, the flares and triggers guide covers that.
Underneath all of it, the question is how you are actually doing.
Community ideas are labeled because they vary by person. They are options, not promises about how another person will respond.
What research says about depression and anxiety
I read a 2010 cohort study that followed more than 145,000 people with psoriasis in a UK general-practice database. It recorded a higher risk of depression, of anxiety, and of suicidality than in people without psoriasis.
The raised depression risk was there in mild psoriasis, and it was larger in severe psoriasis. That is a pattern across a very large group. It does not show that psoriasis caused any one person to become depressed.
What it does establish is that this is measured and expected. People I have heard from ask whether it is normal to feel this low about their skin. You are not raising something strange when you raise it.
Sources for the facts above: Evidence
What research says about skin clinics in general
I checked a 2015 study that screened dermatology outpatients across 13 European countries for depression, anxiety, and suicidal thinking. It had a comparison group without a skin condition.
Clinical depression was roughly twice as common in the patient group. Anxiety and suicidal thinking were also reported more often. The study pooled many skin conditions, so it does not give a psoriasis-only figure.
It is still worth knowing, because it describes the waiting room you are actually sitting in. This is common there, and it is often left unsaid.
Sources for the facts above: Evidence
The itch, sleep, and mood loop
I read a 2023 study of 200 people with psoriasis. People with worse itching had worse sleep on every measure checked. NIAMS lists poor sleep among the symptoms psoriasis can bring.
Broken sleep makes low mood harder to carry, and low mood makes a broken night harder to recover from. Neither source shows which part starts first for any one person.
That matters because the loop can be entered anywhere. Treating the itch, the sleep, or the mood can each loosen it. The itch and sleep guide covers the sleep side in more depth.
Flares track stress, and stress tracks flares
The American Academy of Dermatology lists stress among the things that can trigger a psoriasis flare. A flare is also stressful, which is why this can feel circular.
The same page says triggers differ from person to person, and it gives no figure for how often stress sets a flare off. A flare with no clear cause is not proof that you handled something badly.
Naming the loop out loud at a visit is more useful than trying to win it alone. It also stops a flare from being read as a personal failure.
Sources for the facts above: Evidence
What getting help early looks like
You do not have to wait until it feels severe. Some signs are worth raising as soon as you notice them.
I checked what NICE assesses: the skin, the nails, high-impact sites, the impact on daily life, and any joint concerns. The National Psoriasis Foundation suggests bringing a symptom record to an appointment and sharing it.
So a dermatologist is expected to ask about impact. A psoriasis appointment is a legitimate place to say that your mood is part of it, and one sentence is enough to open it.
- Low mood that stays most days, rather than lifting when a flare settles.
- Loss of interest in things you used to want to do.
- Avoiding people, swimming, the gym, or appointments because of your skin.
- Hopelessness, or a sense that nothing is going to change.
- Any thoughts of harming yourself.
Sources for the facts above: Evidence Evidence
Ask your care teamIf you are in danger right now
If you are in danger right now, treat it as an emergency - that comes before anything else.
In the United States, call or text 988 for crisis support by call, text, or chat. If you think you are in immediate danger of harming yourself, contact emergency services or a crisis line where you are.
Crisis services differ by location; nothing here can identify the right local service or assess your safety. If you are not sure it counts as an emergency, treat it as one and reach out anyway.
Mood and systemic treatment, in general terms
Some psoriasis treatments have carried mood warnings, and asking about that in general terms is a fair thing to do.
The National Psoriasis Foundation records that depression was documented in some trial patients taking Otezla (apremilast), an oral treatment for psoriasis and psoriatic arthritis. That is one named treatment, and the page gives no rate.
I would ask whether anything you take, or are being offered, has a recorded effect on mood. The person prescribing can answer that for your case.
Sources for the facts above: Evidence
Lived experience - varies by person
What people say about getting support
The decision to ask for help does not look the same for everyone, and it does not always happen right away.
Some people say a therapist or counselor helped them separate how their skin looks from how they feel about themselves. A long flare tends to fuse those into one problem.
Some people say they waited years before mentioning any of this to a clinician. It felt like a separate complaint from the skin, or a past appointment had already made them feel dismissed. Bringing a specific question, like the ones below, can make it easier to start.
Bring to your next visit
You can use these as written or change the words. Saving keeps a question on this device.
Can we talk about how psoriasis is affecting my mood, sleep, or daily life as part of my care?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Given how often depression and anxiety are reported alongside psoriasis, would a referral for extra support make sense now, rather than waiting?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Does ___, the treatment I am on or being offered, have a recorded effect on mood?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Archives of Dermatology (Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM)Observational study · Clinical research, tier 2Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: Funding and conflict notes were not checked beyond the published record. So the status here is set to not established.
What this source supports
Supports that one study used a UK family-doctor database. It tracked more than 145,000 people with psoriasis. It also tracked a much larger group with no psoriasis. Supports a higher rate of noted depression in the psoriasis group. Supports a higher rate of noted anxiety. Supports a higher rate of noted self-harm risk. Supports that the rise in depression showed up in mild psoriasis. Supports that the rise was larger in severe psoriasis.
What it does not support
Does not show that psoriasis causes any of this. Does not judge or predict one person. It counts only what a doctor wrote down. So it misses what was never raised in a visit. It covers one database and one span of years. It does not describe US care today.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Journal of Investigative Dermatology (Dalgard FJ, Gieler U, Tomas-Aragones L)Observational study · Clinical research, tier 2Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: Funding and conflict notes were not checked beyond the published record. So the status here is set to not established.
What this source supports
Supports that skin-clinic patients in 13 European countries were screened. They were screened for low mood, for worry, and for thoughts of self-harm. A group with no skin problem was screened too. Supports that low mood was about twice as common in the patient group. Supports that worry was more common in the patient group. Supports that thoughts of self-harm were more common there too. Supports that psoriasis was one of the skin problems in the study.
What it does not support
Does not split psoriasis out from the other skin problems. Does not give a figure for psoriasis alone. It looked at people at one point in time. So it cannot show what came first. Does not judge or predict one person. It was run in Europe and does not describe US care today.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- Scientific Reports (Zaky MS, Elgamal EA, Mohamed DH, Abd Al Maksoud AA, Elsaie ML)Observational study · Clinical research, tier 2Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: Government research-funding acknowledgment only (Egypt STDF/EKB); the authors state no competing interests.
What this source supports
Supports that in a study of 200 people with psoriasis, 16% had poor sleep quality overall. That rose to 50% among people with severe psoriasis and 25% with moderate psoriasis, against 11.8% with mild psoriasis. Supports that people with worse itching had much worse sleep on every measure checked. Supports that higher disease-severity scores lined up with worse sleep quality, shorter sleep, and more sleep disturbance. Both links were strong enough that chance alone is an unlikely explanation.
What it does not support
A single-hospital study in Egypt. It had no comparison group and mostly mild-to-moderate cases. Sleep was measured with a questionnaire, not a sleep lab. It shows a pattern across a group, not that itching causes poor sleep. It does not predict any one person’s sleep.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that poor sleep quality is a listed symptom of psoriasis. Also lists patches of thick, red, scaly skin that itch or burn, and dry, cracked skin that itches or bleeds. Supports that psoriasis carries risk for mental-health concerns including low self-esteem, anxiety, and depression. Supports that managing common triggers, such as stress and skin injuries, can help keep symptoms under control. Supports, by subtype, that guttate psoriasis outbreaks are often triggered by an upper respiratory infection such as strep throat. Also supports that pustular psoriasis symptoms can be triggered by medications, infections, stress, or certain chemicals. Also supports that erythrodermic psoriasis can be triggered by a bad sunburn or certain medications including corticosteroids. Also supports, by subtype, that inverse psoriasis appears as smooth patches of inflamed skin in skin folds. It names the armpits, the groin, and under the breasts as those folds. It records that rubbing and sweating can make inverse psoriasis worse.
What it does not support
Does not give a percentage of patients affected. Does not measure how much sleep is lost. Does not establish that treating the skin fixes the sleep problem for any one person. Its trigger information is organized by psoriasis subtype, not as one general list for plaque psoriasis specifically. It counts nothing for inverse psoriasis either. It gives no share of people affected in a fold or genital site, and it names no treatment for one.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that stress can trigger a psoriasis flare. Supports that skin injury - a cut, scrape, sunburn, tattoo, piercing, bug bite, or shaving nick - can trigger a flare near or at that spot. Typically this appears about 10 to 14 days after the injury. Supports that an infection such as strep throat, an earache, or bronchitis can trigger a flare, reported 2 to 6 weeks later. Supports that starting a medication - including lithium, antimalarial drugs, strong corticosteroids, or some blood pressure drugs - can trigger a flare about 2 to 3 weeks after starting it. Supports that cold, dry weather (such as winter or fall) can worsen flares, and that sunburn or spending time in air conditioning can also worsen them. Supports that smoking, or spending time around secondhand smoke, is a reported trigger. Supports that drinking daily, or more than two drinks on several days a week, can make psoriasis treatment have little or no effect. Supports that triggers differ from person to person.
What it does not support
Does not cite a specific study for its trigger list or timing windows, and does not state how many patients experience each trigger. This page displays no revision date; the date recorded here matches the same AAD psoriasis disease microsite's treatment-and-diagnosis page, checked the same day. Does not establish that avoiding a listed trigger will prevent a flare for any one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute for Health and Care ExcellenceGuideline · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports psoriasis assessment across skin, nails, high-impact sites, life impact and joint concerns; same-day specialist assessment for generalised pustular psoriasis or erythroderma; and a treatment map that includes topical, phototherapy and systemic options.
What it does not support
It is UK guidance and does not diagnose a reader, create a US treatment sequence, determine personal urgency from a description, or establish current US labeling or coverage.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Psoriasis FoundationPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports bringing a symptom tracker, kept on paper or on a phone, to share with a doctor at an appointment. Supports clearly describing symptoms and noting changes in severity and affected areas as part of preparing for a visit.
What it does not support
Does not mention photographing skin changes specifically. The page shows no visible byline or update date. The site copyright year, 2026, is used here.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute of Mental HealthPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports seeking professional help when mental-health concerns interfere with life and using the U.S.
What it does not support
988 Lifeline or emergency services when there are thoughts of self-harm or immediate danger. The source gives only a 2025 revision year; it does not diagnose a condition, assess an individual’s safety or provide crisis services outside the United States.
- World Health OrganizationPatient education · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports contacting emergency services or a crisis line when a person thinks they are in immediate danger of self-harm.
What it does not support
It does not identify a local service, assess an individual’s safety, or replace emergency help.
- National Psoriasis FoundationPatient education · Patient education, tier 5Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The organization provides patient education, but its editorial and funding independence for this page was not independently reviewed. It is used only for patient-facing treatment-category and combination context.
What this source supports
Supports that Otezla (apremilast) treats psoriasis and psoriatic arthritis by inhibiting PDE4, an enzyme that controls much of the inflammatory action within cells. Supports that it operates similarly to biologic treatments by targeting specific immune-system components. Supports that it comes as a 30 mg tablet requiring a five-day dose-escalation period before reaching the recommended 30 mg twice-daily dose. Supports that continuous use is necessary to maintain benefits. Supports that Otezla has been shown to be safe and effective when taken with methotrexate, and can be combined with phototherapy or topical treatments. Supports common side effects including diarrhea, nausea, tension headaches, and upper respiratory infections. Supports that severe gastrointestinal issues, depression, and weight loss were documented in some trial patients.
What it does not support
Does not report cost, insurance coverage, patient-assistance-program terms, or comparative-effectiveness data against other psoriasis treatments, and does not assess an individual reader’s risk.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.